Although the TRAIL-based strategy has been demonstrated to induce cell death in an extensive spectrum of cancer cells including brain tumor cells, a considerable proportion of malignant cells are still resistant to TRAIL-induced apoptosis. This evidence concerns the gene TNFSF10 and brain neoplasm.